Results 11 to 20 of about 6,346 (180)

Tolosa-Hunt syndrome with general myasthenia gravis involvement [PDF]

Journal of Integrative Neuroscience, 2020
Tolosa-Hunt syndrome is an uncommon disease that exhibits unilateral periorbital pain or headache, accompanied by cranial nerve palsies. Myasthenia gravis is an acquired immune system disease involving the neuromuscular junction.
Lu Li, Zhe Wang, Ming-Ou Lu
doaj   +1 more source

Case report: Efgartigimod is a novel therapeutic option for ocular myasthenia gravis: a report of 2 cases [PDF]

Frontiers in Immunology
Ruixia Zhu, Zhu Ruixia
exaly   +2 more sources

Features of depression development in myasthenia gravis.

Medičnì Perspektivi, 2020
The relative risk of developing depression in myasthenia gravis is 2.14 times higher than in the general population. The features of depression in myasthenia patients remain poorly understood and need to be clarified.
O. I. Kalbus, S. O. Makarov, N. P. Shastun, O. V. Somilo, Yu. V. Bukreyeva   +4 more
doaj   +1 more source

Ocular myasthenia

Neurologijos seminarai, 2022
Myasthenia gravis is a chronic autoimmune neuromuscular disorder typically presenting with variable skeletal muscle fatigue. The most prevalent initial manifestation of myasthenia is ocular myasthenia.
J. Zakaravičiūtė, M. Šerelytė
doaj   +3 more sources

Clinical predictors for the prognosis of myasthenia gravis

BMC Neurology, 2017
Background Clinical predictors for myasthenia gravis relapse and ocular myasthenia gravis secondary generalization during the first two years after disease onset remain incompletely identified.
Lili Wang, Yun Zhang, Maolin He
doaj   +1 more source

Ocular myasthenia gravis: Side effect of urografin

Heart India, 2016
Ocular myasthenia gravis is an autoimmune disorder of the neuromuscular junction. Diplopia and ptosis are common symptoms at the onset of ocular myasthenia gravis. It may occur due to the antibodies developed against various drugs.
Nitin Modi, Siddhant Jain, Mahendra Tilkar, Narayan Chandra Sarkar   +3 more
doaj   +1 more source

New acute onset of ocular myasthenia gravis after COVID-19 vaccine: A case report

Journal of Family Medicine and Primary Care, 2023
Reports have shown the association of coronavirus disease 2019 (COVID-19) with several neuromuscular disorders. Myasthenia gravis (MG) is an autoimmune disease in which antibodies bind to acetyl choline receptors in the postsynaptic membrane at the ...
Himani T. Chaturvedi, Varsha Patel, Rahul Vasava, Chandrashekher Chaturvedi   +3 more
doaj   +1 more source

Off-center presentation of ocular myasthenia

Kerala Journal of Ophthalmology, 2022
Myasthenia gravis is an autoimmune condition with varied presentations. In this, we report a 70 years old diabetic male who came complaining of diplopia.
Mary A Stephen, P Jayasri, P J Harigaravelu   +2 more
doaj   +1 more source

Consistent improvement with eculizumab across muscle groups in myasthenia gravis

Annals of Clinical and Translational Neurology, 2020
Objective To assess whether eculizumab, a terminal complement inhibitor, improves patient‐ and physician‐reported outcomes (evaluated using the myasthenia gravis activities of daily living profile and the quantitative myasthenia gravis scale ...
Renato Mantegazza, Fanny L. O'Brien, Marcus Yountz, James F. Howard Jr, for the REGAIN study group   +4 more
doaj   +1 more source

Diplopia in a patient presenting with “blurred vision”: a case report

Journal of Medical Case Reports, 2023
Background Myasthenia gravis is an autoimmune condition affecting the neuromuscular junction and causing muscle weakness along with fatigue (myasthenia).
Anil Harrison, Onkar Mudhar, Jun Yoo, Mayank Rampal   +3 more
doaj   +1 more source